Medline Inc.MDLN

NasdaqHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$34.66
Market cap
$29.8B
P/E
25.7x
Revenue (FY)
$28.4B
Net income
$1.2B
Dividend yield
—
1-year total return
—
Net margin
4.1%
Revenue growth
11.5%
Debt / equity
1.17x

What Medline Inc. does.

Medline Inc. (together with its subsidiaries, “Medline”, “the Company”, “we”, “ours” and “us”) is the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. Medline was founded in 1966 and today delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. Our mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes.

We have two reportable segments, Medline Brand and Supply Chain Solutions, the combination of which addresses critical needs in the market through a comprehensive solution. They are both supported by our Prime Vendor model, differentiated distribution network, and robust commercial platform. Through our two segments, we offer approximately 335,000 med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. We distribute these products through our expansive network o f glob al distribution facilities and our owne d fleet of MedTrans trucks.

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue—$23.2B$25.5B$28.4B
Net income—$234.0M$1.2B$1.2B
Free cash flow—$1.4B$1.4B$1.3B

More on MDLN.

Figures from Medline Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.